4//SEC Filing
Cordell Kevin D 4
Accession 0001235802-19-000136
CIK 0001492658other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:07 PM ET
Size
21.8 KB
Accession
0001235802-19-000136
Insider Transaction Report
Form 4
Cordell Kevin D
Pres., Lower Extremities & Bio
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2019-11-21−67,142→ 0 totalExercise: $20.62Exp: 2025-10-13→ Ordinary Shares (67,142 underlying) - Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-21$20.62/sh+67,142$1,384,468→ 140,955 total - Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-21$24.49/sh+9,066$222,026→ 215,313 total - Sale
Ordinary Shares, par value EUR 0.03 per share
2019-11-21$29.50/sh−141,500$4,174,420→ 73,813 total - Exercise/Conversion
Stock Option (right to buy)
2019-11-21−48,707→ 9,808 totalExercise: $21.24Exp: 2026-07-19→ Ordinary Shares (48,707 underlying) - Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-21$21.24/sh+48,707$1,034,537→ 189,662 total - Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-21$27.86/sh+16,585$462,058→ 206,247 total - Exercise/Conversion
Stock Option (right to buy)
2019-11-21−16,585→ 12,926 totalExercise: $27.86Exp: 2027-07-25→ Ordinary Shares (16,585 underlying) - Exercise/Conversion
Stock Option (right to buy)
2019-11-21−9,066→ 19,957 totalExercise: $24.49Exp: 2028-07-24→ Ordinary Shares (9,066 underlying)
Footnotes (7)
- [F1]Exercise and sale of vested stock options in connection with 280G tax planning.
- [F2]Includes 5,091 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 13,111 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 14,263 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $29.52, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- [F4]This option has fully vested.
- [F5]This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
- [F6]This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
- [F7]This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
Documents
Issuer
Wright Medical Group N.V.
CIK 0001492658
Entity typeother
Related Parties
1- filerCIK 0001393264
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 4:07 PM ET
- Size
- 21.8 KB